SCHEMBL10137675

SCHEMBL10137675

C=CCOC(=O)c1cc(C)cc(C(=O)OCc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.54
TDP1 Q9NUW8 3/20 0.54
SLC6A2 P23975 1/20 0.54
SLC6A3 Q01959 1/20 0.54
LMNA P02545 4/20 0.50
CYP3A4 P08684 1/20 0.49
MAPT P10636 5/20 0.48
ALDH1A1 P00352 5/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 4/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 2/20 0.44
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PRKCA P17252 1/20 0.43
PRKCD Q05655 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6279011 0.93 TDP1 (0.62) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL10137663 0.86 TDP1 (0.54) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL17769232 0.86 KMT2A (0.69) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL12020911 0.85 TDP1 (0.68) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL13465177 0.84 KMT2A (0.62) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL15695711 0.82 CYP3A4 (0.50) KMT2ATDP1LMNACYP3A4MAPT
SCHEMBL6282770 0.81 KMT2A (0.81) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL277915 0.80 CYP3A4 (0.77) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL19206950 0.79 KMT2A (0.79) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL12993324 0.79 RAB9A (0.48) KMT2ATDP1SLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120021530-A1 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS WISCONSIN ALUMNI RESEARCH FOUNDATION 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021530-A1 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS DNPEP, PRKCSH, YWHAZ KMT2A 3597/4885TDP1 2264/4885SLC6A2 4810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.